retatrutide weight loss study results Results: 24% in 48 Weeks Retatrutide for weight loss: Study

Since coverage for weight loss medications is often subject to change, its best to review your plan regularly

Reference: Effects of GLP-1 receptor agonists on kidney and cardiovascular disease outcomes: a meta-analysis of randomised controlled trials by Sunil V Badve, Anika Bilal, Matthew M Y Lee, Naveed Sattar, Hertzel C Gerstein, Christian T Ruff, John J V McMurray, Peter Rossing, George Bakris, Kenneth W Mahaffey, Johannes F E Mann, Helen M Colhoun, Katherine R Tuttle, Richard E Pratley and Vlado Perkovic, 25 November 2024, The Lancet Diabetes & Endocrinology

The researchers also noted a correlation between glutathione levels and disease activity, suggesting that increasing glutathione levels may help reduce lupus symptoms

62 patients were enrolled in the study, with 32 receiving exenatide and 30 receiving placebos